Professional Documents
Culture Documents
INTRODUCTION
Causes of DMPS:
1. Secondary to X-ray therapy
2. Chemotherapy with alkylating agents
3. Toxic chemicals
4. Idiopathic or not known- referred to as “primary DMPS”
PATHOPHYSIOLOGY
2 Hypotheses
1. DMPS growth of an abnormal clone of cells in the marrow (studies
shown that leukemic cells can suppress the growth of normal cell which
result to hypoplasia and pancytopenia)
2. Abnormal DMPS stem cell line has the ability to differentiate to mature
end stage cells that are abnormal in appearance and function.
(Dyserythropoiesis with ineffective erythropoiesis – ANEMIA WITH
ABNORMAL OVAL MACROCYTIC RED CELL)
CLINICAL PRESENTATION
ERYTHROPOIESIS
- Hallmark of DMPS is dyserythropoiesis
- Abnormal maturation is megaloblastoid in type
signify the resemblance to the
megaloblastic maturation typical of vitamin B12
deficiency.
GRANULOPOIESIS
-dysgranulopoiesis is manifested of left shift with increase in myeloblast
+ Nuclear abnormalities- hyposegmentation (pelger-huet)
- hypersegmentation of neutrophil
+ Granular abnormalities- hypogranulation of neutrophil
- coarse abnormal granules (Pseudo-chediak-higashi)
Difficult to differentiate neutrophil and monocyte in which the neutrophil will
present a monocytoid features seen in Chronic Myelomonocytic Leukemia
PERIPHERAL BLOOD AND BONE MARROW ABNORMALITIES
GRANULOPOIESIS
-French-American-British (FAB) classify DMPS into Type I and Type II blast
TYPE I Blast Type II Blast
Centrally located nucleus Centrally located nuclei
Fine chromatin pattern Slightly more mature chromatin
Prominent nucleolus Lower NC ratio
No cytoplasmic Granules Cytoplasm contains large granules one
Also referred to as abnormal progranulocyte (promyelocyte)
- Total combination of type 1 and 2 blast is used to calculate the percentage blasts.
- Tricot and Coworker reported abnormal localization of immature precursor (ALIP pattern)- prognostic
significance of survival and progression to acute leukemia
- GRANULOPOIESIS – localized in the bone trabeculae
- ERYTHROPOIESIS AND MEGAKARYOPOIESIS – centrally in the marrow space
- ALIP pattern clusters of blast appear in the central marrow
PERIPHERAL BLOOD AND BONE MARROW ABNORMALITIES
MEGAKARYOCYTOPOIESIS
- Maturation arrest, with the majority of megakaryocyte being small to
medium size with a single or bilobed nucleus/
- Cytoplasm: may show vacuolization and lack of granulation
- Rare Cases(giant megakaryocyte with hypersegmentation of nucleus)
- Platelet may appear as swiss cheese appearance
SPECIFIC CLINICOPATHOLOGIC FORMS OF
DYSMYELOPOIETIC SYNDROMES
• May display any of the erythroid change of RA or RARS but may also have
dysgranulopoiesis and peripheral cytopenias of two cell lines
• Although RAEb is considered as DMPS, it has been found that when a child or young
adult presents with a morphologic picture of RAEB, the disease will be rapidly
progressive and should be classified as an M2 ANLL
CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
• FAB did not recognize that CMML might exist in a transition stage between
CMML and acute leukemia
• CMML increase of marrow blast to >20% before supervention of ANLL=
CMML in transformation
CMML in transformation- occur in infants or young children that resembles in
CMML seen in adults.
- deletion of Chromosome 7
- also called Ph1 –negative chronic granulocytic leukemia (CGL) or juvenile CGL
- myelomonocytic syndrome of infants/ monosomy 7 syndrome
REFRACTORY ANEMIA WITH EXCESS BLAST IN
TRANSFORMATION (RAEBIT)
binucleated
micromegakaryocyte
DYSMYELOPOIETIC DISORDERS NOT INCLUDED IN THE FAB
CLASSIFICATION
1. Refractory Cytopenia not meeting criteria for RA, RARS, RAEB or CMML
2. Secondary or Therapy related
3. Postleukemic
4. Single cell line Aplaisas
5. Paroxysmal Nocturnal Hemoglobinuria
6. RARS with Isodecentric X Abnormalities
7. Dyrsmegakaryocytopoiesis
1. With the 5q- Chromosome abnormalities
2. Without the 5q- chromosome abnormalities
8. Acute myelodysplasia with myelofibrosis
Refractory Cytopenia not meeting criteria for RA,
RARS, RAEB or CMML